The World Health Organization (WHO) reported on Monday (15) that it authorized the emergency use of the COVID-19 vaccine developed by AstraZeneca in partnership with the University of Oxford, COVAX, which will be produced at AstraZeneca-SKBio, in South Korea and the Serum Institute in India. The decision also allows vaccines to be distributed through the Covax Facility program, a WHO initiative to help developing countries gain access to coronavirus vaccines.
This text was translated by machine from Brazilian Portuguese.